Prostate Cancer Diagnostic

Cellanyx’s lead test in development is a diagnostic to stratify the risk of local tumor spread and metastasis in men with prostate cancer – low and intermediate risk Gleason grades. The test provides a quantitative, actionable assessment to aid clinical decision making.